chr11-121113065-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP7BP4
This summary comes from the ClinGen Evidence Repository: The c.487-7C>G intronic variant in TECTA was present in 0.05081% (18/35428) of Latino alleles in gnomAD; however, because this gene has been associated with both AR and AD hearing loss, no criteria were applied based on population data. This variant was identified in 1 white patient with nonsyndromic hearing loss (PS4 not met; Laboratory for Molecular Medicine internal data, SCV000272492.3). The c.487-7C>G variant is classified as likely benign because a C>G change at this position does not diverge from the splice consensus sequence, making it unlikely to impact splicing, and computational splice prediction tools do not predict an impact on splicing. ACMG/AMP Criteria applied, as specified by the Hearing Loss Expert Panel: BP4, BP7. LINK:https://erepo.genome.network/evrepo/ui/classification/CA6326508/MONDO:0019497/005
Frequency
Consequence
NM_005422.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TECTA | NM_005422.4 | c.487-7C>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000392793.6 | NP_005413.2 | |||
TBCEL-TECTA | NM_001378761.1 | c.1444-7C>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NP_001365690.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TECTA | ENST00000392793.6 | c.487-7C>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 5 | NM_005422.4 | ENSP00000376543 | P4 | |||
TECTA | ENST00000264037.2 | c.487-7C>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | ENSP00000264037 | P4 | ||||
TECTA | ENST00000642222.1 | c.487-7C>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENSP00000493855 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000107 AC: 27AN: 251206Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135820
GnomAD4 exome AF: 0.0000554 AC: 81AN: 1461774Hom.: 0 Cov.: 31 AF XY: 0.0000495 AC XY: 36AN XY: 727182
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 01, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 26, 2015 | Variant classified as Uncertain Significance - Favor Benign. The c.487-7C>G vari ant in TECTA has been previously identified in our laboratory in one individual with hearing loss. This variant has been identified in several populations and was present in 10/120696 of the total chromosomes by the Exome Aggregation Conso rtium (ExAC, http://exac.broadinstitute.org; dbSNP rs368627411). This variant is located in the 3' splice region. Computational tools do not suggest an impact t o splicing; however, this information is not predictive enough to rule out patho genicity. In summary, while the clinical significance of the c.487-7C>G variant is uncertain, these data suggest it is more likely to be benign. - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 12, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 27, 2018 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Nonsyndromic genetic hearing loss Benign:1
Likely benign, reviewed by expert panel | curation | ClinGen Hearing Loss Variant Curation Expert Panel | Oct 02, 2019 | The c.487-7C>G intronic variant in TECTA was present in 0.05081% (18/35428) of Latino alleles in gnomAD; however, because this gene has been associated with both AR and AD hearing loss, no criteria were applied based on population data. This variant was identified in 1 white patient with nonsyndromic hearing loss (PS4 not met; Laboratory for Molecular Medicine internal data, SCV000272492.3). The c.487-7C>G variant is classified as likely benign because a C>G change at this position does not diverge from the splice consensus sequence, making it unlikely to impact splicing, and computational splice prediction tools do not predict an impact on splicing. ACMG/AMP Criteria applied, as specified by the Hearing Loss Expert Panel: BP4, BP7. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at